AlphaSimPlex Group’s Amgen AMGN Stock Holding History

AlphaSimPlex Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-992	Closed	-$242K	–	213
2021 Q2	$242K	Hold	992	–	–	0.12%	217
2021 Q1	$247K	Buy	+992	New	+$237K	0.1%	241

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AlphaSimPlex Group's AMGN Position: Q3 2021 in Review

AlphaSimPlex Group sold out of Amgen (AMGN) in Q3 2021, closing a stake of 992 shares — an estimated $242K sold.

AlphaSimPlex Group first reported a position in AMGN in Q1 2021 and held it in 2 quarters. The position peaked at $247K in Q1 2021. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

AlphaSimPlex Group reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
AlphaSimPlex Group sold 992 Amgen shares in Q3 2021, an estimated $242K.
AlphaSimPlex Group first reported a position in Amgen in Q1 2021 and held it in 2 quarters.
AlphaSimPlex Group's Amgen position peaked at $247K in Q1 2021.
2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on AlphaSimPlex Group's 13F filing for Q3 2021, filed 15 Nov 2021.